WYNDHAM HOTELS & RESORTS, INC. (WH) Form 8-K — May 18, 2026
Wyndham Hotels & Resorts CEO Geoff Ballotti disclosed a diagnosis of Multiple Myeloma, a highly treatable form of bone cancer, but confirmed he will continue working largely as normal with only reduced travel. The Board supports this approach, and Ballotti emphasized a favorable prognosis and early detection, signaling continuity in leadership. The filing also reports results from the May 14, 2026 Annual Meeting, where stockholders approved the election of all nine director nominees and ratified Deloitte & Touche LLP as the independent auditor.
Key figures
- Ceo votes for
- 63889817
- Say on pay for
- 54328340
- Ceo votes against
- 59659
- Say on pay against
- 9548555
- Stockholder proposal for
- 40181784
- Stockholder proposal against
- 23709518
Price after filing
Close on the filing date to close N calendar days later (from $78.14). Historical, not a forecast.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.